Projects funded by the NCN
Inhibition of activity tryptophan hydroxylase-1 - the new conception in the treatment of mineral and bone disorders in chronić reanal failure.
2013/09/B/NZ7/00046
Keywords:
tryptophan hydroxylase-1 inhibitor serotonin bone and mineral disorders experimental chronic renal failure
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Medyczny w Białymstoku, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej
woj. podlaskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 9
Call: OPUS 5 - announced on 2013-03-15
Amount awarded: 729 685 PLN
Project start date (Y-m-d): 2014-03-21
Project end date (Y-m-d): 2018-03-20
Project duration:: 48 months (the same as in the proposal)
Project status: Project settled